Stock ZVSA ZYVERSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. ZyVersa Therapeutics, Inc.

Equities

ZVSA

US98987D3008

Real-time Estimate Cboe BZX
Other stock markets
 11:11:09 2024-06-07 EDT 		5-day change 1st Jan Change
4.76 USD +0.21% Intraday chart for ZyVersa Therapeutics, Inc. -2.53% -46.50%
05-15 ZyVersa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-25 ZyVersa Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HC Wainwright Cuts Price Target on ZyVersa Therapeutics to $12 From $24, Maintains Buy Rating
MT
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike
MT
HC Wainwright Starts ZyVersa Therapeutics With Buy Rating, Price Target is $2.50
MT
ZyVersa Therapeutics, Inc. Announces Article Published in Metabolism Pointing to Glomerular Cholesterol Accumulation as Key Factor Exacerbating Renal Injury and Dysfunction in Diabetic Kidney Disease
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZVSA Stock
  4. News ZyVersa Therapeutics, Inc.
  5. Analyst Reco.